Fighting brain cancer at its root
McGill University researchers identify proteins that drive cancer stem cells. Targeting and supressing a particular protein called galectin1 could provide a more effective treatment for glioblastoma, in combination with radiation therapy.
Brain connectivity can build better AI
Artificial neural networks modeled on real brains can perform cognitive tasksA new study shows that artificial intelligence networks based on human brain connectivity can perform cognitive tasks efficiently.
Message from VP-Dean Eidelman - The Faculty's Return to Campus
Dear Faculty of Medicine and Health Sciences Colleagues,
Six New Canada Research Chairs, and Three Renewals for McGill
Today, at l'Université du Québec à Trois-Rivières, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry announced investments of more than $635 million for science, research, and engineering in Canada.
Marathon of Hope Cancer Centres Network accelerates precision medicine plan with signing of Contribution Agreement with Health Canada
Vancouver, BC -- The Government of Canada and the Terry Fox Research Institute (TFRI) have jointly signed a Contribution Agreement which opens the door for the Marathon of Hope Cancer Centres Network to begin operating.
Vitamin D may not protect against COVID-19, as previously suggested
While previous research early in the pandemic suggested that vitamin D cuts the risk of contracting COVID-19, a new study from McGill University finds there is no genetic evidence that the vitamin works as a protective measure against the coronavirus.
McGill researcher-led International Task Force unveils first-of-its kind standards for treatment of obsessive-compulsive disorder
By David McFadden
Listed by the World Health Organization among the ten leading causes of medical disability worldwide, the severity of obsessive-compulsive disorder (OCD) is at a level on par with cancer. This prevalent disorder is characterized by highly distressing intrusive thoughts and repeated compulsive behaviours such as washing or checking.
Two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
A team of researchers at the RI-MUHC found two cellular pathways involved in TNBC tumour development and a promising targeted combination therapy
Source: RI-MUHC
Introducing the science world to a unique Quebec COVID-19 resource
PLOS ONE publishes foundational article on the Biobanque québécoise de la COVID-19 (BQC19)
Message from VP-Dean Eidelman - Planning for a return to campus
Dear members of our Faculty community,
Our world has changed since the onset of the COVID-19 pandemic, yet we have persevered to continue to offer world-class education and conduct leading research. Indeed, I am immensely proud of our contributions.
Study shows how our brains sync hearing with vision
To make sense of complex environments, brain waves constantly adapt, compensating for drastically different sound and vision processing speeds
Every high-school physics student learns that sound and light travel at very different speeds. If the brain did not account for this difference, it would be much harder for us to tell where sounds came from, and how they are related to what we see.
A sweet solution to hard brain implants
Study uses sugar to make and deliver pudding-like brain implants that reduce foreign body response
Brain implants are used to treat neurological dysfunction, and their use for enhancing cognitive abilities is a promising field of research. Implants can be used to monitor brain activity or stimulate parts of the brain using electrical pulses. In epilepsy, for example, brain implants can determine where in the brain seizures are happening.
Dr. Joanne Liu joins McGill University
Dr. Joanne Liu, a Canadian pediatric emergency room physician and former International President of Médecins Sans Frontières/Doctors Without Borders (MSF) is joining McGill University’s School of Population and Global Health (SPGH) as a professor focusing on pandemic and health emergencies.
Under 30 and sexually active? It’s a good idea to get tested for chlamydia and gonorrhea
Canadian Task Force on Preventive Health Care recommends routine screening
Source: CMAJ
Anyone sexually active under age 30 should be offered testing for chlamydia and gonorrhea, according to a new guideline from the Canadian Task Force on Preventive Health Care published in CMAJ (Canadian Medical Association Journal).
International platform for sharing cardiovascular data launched by euCanSHare
McGill's Professor Bartha Maria Knoppers to co-lead the work package on ethics and interoperability.